Cambridge Antibody Technology (CAT) is expanding its operations in Cambridge, UK, by leasing the building currently known as Unit GP15 on Granta Park, the science park near Cambridge where the company has two facilities. Unit GP15, which was previously occupied by Millennium Pharmaceuticals and was vacated in 2003, will provide CAT with an additional 92,000 sq. ft. of state-of-the-art laboratory and associated open-plan office space. The company plans to alter the internal layout of the bui...